Evidence map›Paper›PMID 26074972›Full record

ArticleStem cells international2015

Octanoate in Human Albumin Preparations Is Detrimental to Mesenchymal Stromal Cell Culture.

Way-Wua Wong, Andrew D MacKenzie, Vicky J Nelson, James M Faed, Paul R Turner

Open access · goldAbstract read
In one paragraph

Article in Stem cells international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Way-Wua WongSpinal Cord Society New Zealand, Centre for Innovation, 87 St David Street, Dunedin 9054, New Zealand.
Andrew D MacKenzieCallaghan Innovation, 69 Gracefield Road, Lower Hutt 5040, New Zealand.
Vicky J NelsonSpinal Cord Society New Zealand, Centre for Innovation, 87 St David Street, Dunedin 9054, New Zealand.
James M FaedSpinal Cord Society New Zealand, Centre for Innovation, 87 St David Street, Dunedin 9054, New Zealand.
Paul R TurnerSpinal Cord Society New Zealand, Centre for Innovation, 87 St David Street, Dunedin 9054, New Zealand.
Cancer Society of New Zealand · NZCallaghan Innovation · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell therapies hold great promise as the next major advance in medical treatment. To enable safe, effective ex vivo culture whilst maintaining cell phenotype, growth media constituents must be carefully controlled. We have used a chemically defined mesenchymal stromal cell culture medium to investigate the influence of different preparations of human serum albumin. We examined two aspects of cell culture, growth rate as measured by population doubling time and colony forming ability which is a representative measure of the stemness of the cell population. Albumin preparations showed comparative differences in both of these criteria. Analysis of the albumin bound fatty acids also showed differences depending on the manufacturing procedure used. We demonstrated that octanoate, an additive used to stabilize albumin during pasteurization, slows growth and lowers colony forming ability during ex vivo culture. Further to this we also found the level of Na(+)/K(+) ATPase, a membrane bound cation pump inhibited by octanoate, is increased in cells exposed to this compound. We conclude that the inclusion of human serum albumin in ex vivo growth media requires careful consideration of not only the source of albumin, but also the associated molecular cargo, for optimal cell growth and behavior.

Identifiers

PMID26074972
PMCPMC4444585
OpenAlexW1590117684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.